U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07564895) titled 'Impact of BAFF Gene Polymorphisms on the Risk of Ulcerative Colitis and the Efficacy of Vedolizumab.' on April 27.
Brief Summary: Relationships of B-cell Activating Factor Gene Polymorphisms With ulcerative colitis.
Study Start Date: March 01, 2018
Study Type: OBSERVATIONAL
Condition:
Ulcerative Colitis (UC)
Recruitment Status: COMPLETED
Sponsor: Second Affiliated Hospital of Wenzhou Medical University
Published by HT Digital Content Services with permission from Health Daily Digest....